Selecting Treatment for Late-Stage SCLC
Afshin Dowlati, MD, discusses treatment decision-making for patients with late-stage small cell lung cancer.
Frontline Targeted Options for EGFR-Mutated NSCLC
Afshin Dowlati, MD, discusses the targeted therapies available for patients with EGFR-mutated late-stage non–small cell lung cancer.